JC Virus Testing 101: What You Need to Know About JC Virus Testing in Multiple Sclerosis Care Authors: Heinz Wiendl, MD; Wallace Brownlee, MBChB, PhD, FRACP +++

https://www.medscape.org/viewarticle/1002825?src=mkmcmr_driv_32025_mscpedu_430341.22_ace_launch-Ret&sso=true&uac=148436CN Integrating Biosimilars into Multiple Sclerosis Care Multiple sclerosis (MS) disease burden represents a significant challenge for patients and their families. However, a recent report has indicated that the economic burden is the most common challenge affecting access to MS therapy in 46% of 90 countries. In this light, biosimilars are now being integrated into clinical practice for patients with MS. Clinicians need to know how to discuss their use with patients and to interpret risk stratification test results when necessary. This educational curriculum covers best practices in communicating about biosimilars and the science behind new risk assessment assays and their integration into clinical practice. https://www.medscape.org/advances/biosimilars-multiple-sclerosis-2025a1000hjl?uac=148436CN&sso=true&src=mkmcmr_driv_32025_mscpedu_430341.22_ace_launch-Ret Interpreting JC Virus Test Results in Multiple Sclerosis Management: Are You Up to Speed? Authors: Gavin Giovannoni, MD; Orhan Aktas, MD, PhD; Ruth Dobson, MD, PhD https://www.medscape.org/viewarticle/interpreting-jc-virus-test-results-multiple-sclerosis-2025a1000qzm?page=1&uac=148436CN&src=mkmcmr_driv_32025_mscpedu_430341.22_ace_launch&sso=true